TRADING HALTED

ReNeuron Group PLC RQE1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 02/05/24 CEST
0.042UNCH (UNCH)
52 week range
0.00 - 0.13
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.042
  • 52 Week High0.13
  • 52 Week High Date08/17/23
  • 52 Week Low0.00
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap2.44M
  • Shares Out57.17M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-1.45

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.042
  • 52 Week High0.13
  • 52 Week High Date08/17/23
  • 52 Week Low0.00
  • 52 Week Low Date10/25/23
  • Market Cap2.44M
  • Shares Out57.17M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-1.45

RATIOS/PROFITABILITY

  • EPS (TTM)-0.10
  • P/E (TTM)-0.42
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ReNeuron Group PLC

 

Content From Our Affiliates

Profile

MORE
ReNeuron Group plc is a United Kingdom-based Stem Cell and Exosome Technologies company that utilizes its stem cell technologies to develop treatments for disease with unmet needs. The Company has developed a proprietary stem cell-derived, exosome-based, drug delivery platform with customizable cellular targeting capabilities for the delivery of complex drug modalities. The Company’s CustomEX platform can be optimized for specific tissues targets and payloads leading to...
Iain Ross
Executive Chairman of the Board
Suzanne Hancock
Chief Operations Officer
John Hawkins
Chief Financial Officer, Director
Address
Pencoed Business Park
Bridgend
CF35 5HY
United Kingdom